All posts by : Felistas

The World Health Organization called Thursday for greater efforts to combat measles, which is spreading in 58 countries including the United States, where two children have died.

Seventeen modifiable risk factors are shared by stroke, dementia, and late-life depression, according to a review published online April 3 in the Journal of Neurology, Neurosurgery & Psychiatry.

A team of University of Kentucky Markey Cancer Center researchers has found the mechanism that grants prostate cancer resistance to enzalutamide, a frequently used drug. The article is published in Science Signaling.

GRACE CHAILE BUSINESSMAN Francis Muchemwa, also known as Intercity Commander 2, has appealed to the High Court to acquit him of corruption charges, claiming he was subjected to an unfair trial. Muchemwa was convicted in July 2024 for possessing tainted property, including several properties and vehicles worth K11 million. He is serving a three-year sentence. […]

Therapies that unleash the immune system to fight tumors have greatly extended the lives of people with many types of cancer. But there are reports that patients with melanoma and lung cancer whose disease has spread to the brain may experience serious inflammatory reactions after receiving immunotherapy drugs concurrently with radiation.

The heart of the opioid epidemic that killed 665,341 people in the United States between 2005 and 2020 shifted geographically from the Northwest to the East, according to a new geographical analysis.

Research has shed light on how a new type of antibody treatment reactivates patients’ immune cells to fight ovarian cancer. The research, from the group of Professor Sophia Karagiannis at King’s College London, could help to better understand the responses of patients who receive this type of therapy.

To grow, cancer tumors must hijack the immune system for their needs. One of the main tricks that most tumors use is to manipulate a type of immune cell called a macrophage, causing it to protect the tumor from the rest of the immune system, recruit blood vessels and help the cancer spread to other tissues.

New research to be presented at the European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for weight loss experienced minimal lean muscle mass loss as they lost weight across six months of treatment.

During the COVID-19 pandemic, tuberculosis (TB) mortality surged for the first time in two decades. While these increases were widely attributed to disruptions to TB services, such as diagnostic delays and treatment interruptions, a new study suggests that we may have overlooked the impact of food insecurity during pandemic lockdowns.